Loading organizations...

§ Venture Capital · CA, USA
This venture capital firm invests in science-driven startups from top universities and scientists, aiming to accelerate innovation and create impactful busin...
Kairos Ventures invests in ideas, patents, and businesses from the top universities and scientists. Kairos Venture Investments works to get science into the hands of applicable companies. Their team possesses an extraordinary passion to have a huge impact on our world through the creation of companies that will improve our lives and that of thegenerations that will follow. They aim to do this by backing the very best scientists, engineers and entrepreneurs and help them transform their knowledge, ideas and discoveries into viable businesses. They expect these companies to have a huge impact on the world and create significant returns for their shareholders.
Key people at Kairos Ventures.
Kairos Ventures was founded in 2015 by Jim Demetriades (Managing Partner and Founder).
Kairos Ventures was founded in 2015 by Jim Demetriades (Managing Partner and Founder).
Key people at Kairos Ventures.
Kairos Ventures is a venture capital firm dedicated to investing in science-driven startups emerging from top universities and leading scientists. Their mission is to accelerate innovation by commercializing world-class scientific discoveries into viable businesses that can have a significant global impact. They focus on early-stage investments, typically ranging from $150,000 to $20 million, supporting founders to retain majority ownership while providing hands-on operational support across legal, finance, marketing, and other critical business functions. Key sectors include healthcare, technology, and other science-based industries. Kairos Ventures plays a vital role in the startup ecosystem by bridging the gap between academic research and market-ready companies, fostering innovation that can improve lives and generate substantial shareholder returns[1][3][4].
Founded in 2015 and based in Beverly Hills, California, Kairos Ventures was established by a team of entrepreneurs with diverse backgrounds in building, managing, and selling companies across various industries such as software, hospitality, and luxury goods. This collective experience, totaling over 100 years, informs their approach to venture investing. The firm evolved with a clear focus on backing the best scientists and engineers, helping them transform their knowledge and discoveries into impactful businesses. Their early traction includes 75 investments and multiple portfolio exits, demonstrating a growing influence in the commercialization of scientific innovation[4][5][6].
Kairos Ventures rides the growing trend of translating cutting-edge scientific research into commercial ventures, a critical phase often underserved by traditional venture capital. The timing is favorable due to increasing global emphasis on science and technology innovation, especially in healthcare and technology sectors. Market forces such as rising R&D investments, university-industry collaborations, and demand for breakthrough solutions in health and tech amplify their impact. By nurturing startups from inception, Kairos accelerates the pace at which scientific breakthroughs reach the market, influencing the broader ecosystem by setting a model for science-driven venture investing[1][3][4].
Looking ahead, Kairos Ventures is poised to deepen its influence by continuing to back transformative scientific innovations and expanding its portfolio in emerging tech and healthcare sectors. Trends such as AI integration in life sciences, personalized medicine, and sustainable technologies will likely shape their investment focus. Their hands-on operational model and strong network position them well to help startups navigate complex commercialization challenges. As the demand for science-based solutions grows, Kairos Ventures’ role as a bridge between academia and industry will become increasingly critical, potentially leading to larger fundraises and more significant market impact[1][4][6].
Kairos Ventures has 19 tracked investments across 16 companies. The latest tracked deal is $40.0M Series A in Vivodyne in May 2025.